Clinical trials sponsored by Sun Pharmaceutical Industries Limited
3
Recruiting trials
8
Conditions studied
Phase breakdown
Phase 1 1Phase 2 2
Conditions studied
| Condition | Trials |
|---|---|
| Type 2 diabetes | 2 |
| Type II Diabetes Mellitus | 2 |
| Castrate-sensitive | 1 |
| Castrate-sensitive Prostate Cancer | 1 |
| Metastatic Cancer | 1 |
| Neoplasm, Prostate | 1 |
| Obesity | 1 |
| Prostate cancer | 1 |
Recruiting trials led by Sun Pharmaceutical Industries Limited
- Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
- Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
Common questions
How many trials is Sun Pharmaceutical Industries Limited recruiting for?
Sun Pharmaceutical Industries Limited is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.